title: Commentary on Sawangjit et al. (2017): There is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision.
authors.affiliation: Department of Pharmacy and Pharmacology, University of Bath, Somerset, UK.
authors.forename: Jenny
authors.initials: J
authors.lastname: Scott
mesh_terms: D015658:HIV Infections; D006801:Humans; D016485:Needle Sharing; D018671:Needle-Exchange Programs; D015819:Substance Abuse, Intravenous; D013594:Syringes
keywords: Blood borne viruses; coverage; injecting risk; needle and syringe programme; opiate substitution theraphy; pharmacy